Accepted for Publication: May 28, 2022.
Published: July 19, 2022. doi:10.1001/jamanetworkopen.2022.22640
Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2022 Caban-Martinez AJ et al. JAMA Network Open.
Corresponding Author: Alberto J. Caban-Martinez, DO, PhD, MPH, Department of Public Health Sciences, Leonard M. Miller School of Medicine, University of Miami, 1120 NW 14th St, Rm 1035, Miami, FL 33136 (acaban@med.miami.edu).
Author Contributions: Ms Grant and Dr Thompson had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Caban-Martinez, Schaefer-Solle, Thompson, Burgess.
Acquisition, analysis, or interpretation of data: Caban-Martinez, Gaglani, Olsho, Grant, Thompson, Burgess.
Drafting of the manuscript: Caban-Martinez, Thompson, Burgess.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Grant, Thompson.
Obtained funding: Caban-Martinez, Olsho, Thompson, Burgess.
Administrative, technical, or material support: Caban-Martinez, Olsho, Schaefer-Solle, Thompson.
Supervision: Caban-Martinez, Gaglani, Olsho, Thompson.
Conflict of Interest Disclosures: Dr Caban-Martinez reported receiving grants from the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention (CDC) and grants from Federal Emergency Management Agency (FEMA) to investigate cancer risk in US firefighters during the conduct of the study. Dr Gaglani reported receiving institutional grants from the CDC-Abt Associates during the conduct of the study and grants from the CDC, CDC–Abt Associates, CDC–Vanderbilt University Medical Center, CDC-Westat, and Janssen Pharmaceuticals outside the submitted work. Dr Olsho reported receiving grants from the National Center for Immunization and Respiratory Diseases at the CDC during the conduct of the study. Dr Schaefer-Solle reported receiving grants from the CDC during the conduct of the study. Dr Burgess reported receiving grants from the CDC and FEMA during the conduct of the study. No other disclosures were reported.
Funding/Support: This study was supported by contracts 75D30120R68013 (Marshfield Clinic Research Institute), 75D30120C08379 (University of Arizona), and 75D30120C08150 (Abt Associates) from the National Center for Immunization and Respiratory Diseases and the CDC.
Role of the Funder/Sponsor: Investigators from CDC were involved in all aspects of the study, including design and conduct of the study, analysis and interpretation of the data, and preparation, review, and approval of the manuscript. The CDC had the right to control decisions about publication via the CDC publication clearance process.
Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the collaborating institutions.
Additional Information: Data will be made available by the CDC when objectives of the research are complete.
1.Ellingson
KD , Gerald
JK , Sun
X ,
et al. Incidence of SARS-CoV-2 infection among health care personnel, first responders, and other essential workers during a prevaccination COVID-19 surge in Arizona.
JAMA Health Forum. 2021;2(10):e213318. doi:
10.1001/jamahealthforum.2021.3318
Google ScholarCrossref 4.Edwards
LJ , Fowlkes
AL , Wesley
MG ,
et al. Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER): protocol for a multisite longitudinal cohort study.
JMIR Res Protoc. 2021;10(12):e31574. doi:
10.2196/31574
PubMedGoogle ScholarCrossref 5.Lutrick
K , Ellingson
KD , Baccam
Z ,
et al. COVID-19 infection, reinfection, and vaccine effectiveness in a prospective cohort of Arizona frontline/essential workers: the AZ HEROES research protocol.
JMIR Res Protoc. 2021;10(6):e28925. doi:
10.2196/28925
PubMedGoogle ScholarCrossref